Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours
Cited by 9
Related Papers
Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
|Exploration|2021|100
Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression
|Journal of Clinical Investigation|2020|94
The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer
|Journal of Clinical Investigation|2023|63